Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …
Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

